REV1 and lung cancer: The heterozygote of REV1 rs3087386 (F257S) and rs3792136 were independent prognostic factors for lung cancer survival with hazard radio (HR) 1.54 (95% CI: 1.12–2.12) and 1.44 (95% CI: 1.06–1.97) respectively (Xu et al., 2013).